IKBKG and idiopathic CD4 lymphocytopenia: Recently, the concept of a “two hit” hypothesis was advanced by the finding of two ICL patients with CM who had additional autoantibodies to GMCSF or an otherwise benign, but functionally significant mutation in the IKBKG/NEMO gene, with reductions in NFKB T-cell signaling (94).